Breaking News

NovAliX Partners with MPI to Advance Drug Discovery

Aims to make the vital process of translating scientific research and academic insights into real therapies more efficient.

Author Image

By: Charlie Sternberg

Associate Editor

NovAliX, a specialized Contract Research Organization dedicated to enabling drug discovery, has entered a long-term strategic partnership with the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen, through which NovAliX and the MPI aim to make the vital process of translating scientific research and academic insights into real therapies more efficient.   Prof. Dr. Holger Stark, Managing Director at the MPI for Multidisciplinary Sciences, highlights the potential of this pa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters